Jastreboff, AM, Aronne, LJ, Ahmad, NN, et al
Compare Hims, Ro, and Noom Med for GLP-1 weight loss
This program evaluated the efficacy and safety of oral semaglutide in patients with DM2 from monotherapy to insulin addition, including HbA1c and body weight reduction outcomes, in addition to other relevant efficacy and safety endpoints, as compared to both placebo and other common antihyperglycemic drugs
Outcomes and follow-up Primary outcomes were (1) MACEs (composite of acute myocardial infarction, stroke and all-cause mortality) and (2) ESKD (that is, dialysis and kidney transplantation using a validated algorithm) 37
But what does the science really say
Managing anxiety around food, weight plateaus or medication side effects is a real part of the journey for many people